Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRAK-04221
- Development stage
- Preclinical
- Lead developer
- Premas Biotech
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
PRAK-04221 is a virus-like particle (VLP) vaccine candidate developed by Premas Biotech for the prevention of influenza. The vaccine is designed to present influenza virus antigens in a non-infectious VLP format, which mimics the structure of the native virus to elicit a robust and protective antiviral immune response. Developed using Premas Biotech's proprietary D-Crypt™ platform, PRAK-04221 is currently in the preclinical stage of development.
- Other names
- PRAK-04221PRAK04221PRAK 04221
02
Targets
HA0 (Influenza B virus hemagglutinin)TCR (T-cell receptor (TCR) specific for influenza epitopes)B-cell receptor (BCR) specific for influenza hemagglutinin (HA) and neuraminidase (NA) epitopes
Beyond the preview
Go deeper on PRAK-04221.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRAK-04221.